Marker Therapeutics (MRKR) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.53
-0.44
-0.34
-0.25

Details

Expected EPS
-0.30385
Actual EPS
-0.25
Surprise EPS
0.05
Surprise Percent
+17.72%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.25 per share for Q3 2025.

0 Comments

Share your thoughts